Heterogeneity of ERG expression in core needle biopsies of patients with early prostate cancer

Human Pathology

Volumn 44, Issue 12, 2013, Pages 2727-2735

  Mertz, Kirsten D ^a   Horcic, Milo ^b   Hailemariam, Seife ^b   D'Antonio, Antonio ^c   Dirnhofer, Stephan ^d   Hartmann, Arndt ^e   Agaimy, Abbas ^e   Eppenberger Castori, Serenella ^d   Obermann, Ellen ^d   Cathomas, Gieri ^a   Bubendorf, Lukas ^d  

^a Kantonsspital Liestal   (Switzerland)

^b Institut für Histologische und Zytologische Diagnostik AG Aarau   (Switzerland)

^c UNIVERSITY OF SALERNO   (Italy)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Active surveillance; ERG; Heterogeneity; Immunohistochemistry; Prostate cancer

Indexed keywords

ADULT; AGED; ARTICLE; ERG GENE; GENE; GENE EXPRESSION; GENETIC HETEROGENEITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PREVALENCE; PROSTATE CANCER; STAINING;

ACTIVE SURVEILLANCE; ERG; HETEROGENEITY; IMMUNOHISTOCHEMISTRY; PROSTATE CANCER;

AGED; AGED, 80 AND OVER; BIOPSY, LARGE-CORE NEEDLE; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; ONCOGENE PROTEINS, FUSION; PROSTATE; PROSTATIC NEOPLASMS; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84888040250     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.07.019     Document Type: Article

References (29)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. T.J. Wilt, M.K. Brawer, and K.M. Jones Radical prostatectomy versus observation for localized prostate cancer N Engl J Med 367 2012 203 213
3. C. Kumar-Sinha, S.A. Tomlins, and A.M. Chinnaiyan Recurrent gene fusions in prostate cancer Nat Rev Cancer 8 2008 497 511
4. M.A. Rubin, C.A. Maher, and A.M. Chinnaiyan Common gene rearrangements in prostate cancer J Clin Oncol 29 2011 3659 3668
5. V.J. Scheble, M. Braun, and R. Beroukhim ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor Mod Pathol 23 2010 1061 1067
6. M. Barry, S. Perner, F. Demichelis, and M.A. Rubin TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications Urology 70 2007 630 633
7. B. Furusato, C.L. Gao, and L. Ravindranath Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer Mod Pathol 21 2008 67 75
8. R. Mehra, B. Han, and S.A. Tomlins Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases Cancer Res 67 2007 7991 7995
9. S. Minner, M. Enodien, and H. Sirma ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy Clin Cancer Res 17 2011 5878 5888
10. S. Minner, M. Gartner, and F. Freudenthaler Marked heterogeneity of ERG expression in large primary prostate cancers Mod Pathol 26 2013 106 116
11. K. Park, S.A. Tomlins, and K.M. Mudaliar Antibody-based detection of ERG rearrangement-positive prostate cancer Neoplasia 12 2010 590 598
12. J.M. Mosquera, R. Mehra, and M.M. Regan Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States Clin Cancer Res 15 2009 4706 4711
13. B. Delahunt, R.J. Miller, J.R. Srigley, A.J. Evans, and H. Samaratunga Gleason grading: past, present and future Histopathology 60 2012 75 86
14. S. Hailemariam, J. Vosbeck, and G. Cathomas Can molecular markers stratify the diagnostic value of high-grade prostatic intraepithelial neoplasia? Hum Pathol 42 2011 702 709
15. H.A. van Vugt, M.J. Roobol, and H.G. van der Poel Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study BJU Int 110 2012 180 187
16. T.J. Wilt, M.K. Brawer, and M.J. Barry The Prostate Cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer Contemp Clin Trials 30 2009 81 87
17. J.L. Fleiss Measuring nominal scale agreement among many raters Psychol Bull 76 1971 378 382
18. R. Arora, M.O. Koch, J.N. Eble, T.M. Ulbright, L. Li, and L. Cheng Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate Cancer 100 2004 2362 2366
19. D.G. Bostwick, A. Shan, and J. Qian Independent origin of multiple foci of prostatic intraepithelial neoplasia: comparison with matched foci of prostate carcinoma Cancer 83 1998 1995 2002
20. A. Marusyk, V. Almendro, and K. Polyak Intra-tumour heterogeneity: a looking glass for cancer? Nat Rev Cancer 12 2012 323 334
21. E.T. Ruijter, C.A. van de Kaa, J.A. Schalken, F.M. Debruyne, and D.J. Ruiter Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications J Pathol 180 1996 295 299
22. A.M. Wise, T.A. Stamey, J.E. McNeal, and J.L. Clayton Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens Urology 60 2002 264 269
23. S. Perner, J.M. Mosquera, and F. Demichelis TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion Am J Surg Pathol 31 2007 882 888
24. Y. Miyagi, T. Sasaki, and K. Fujinami ETS family-associated gene fusions in Japanese prostate cancer: analysis of 194 radical prostatectomy samples Mod Pathol 23 2010 1492 1498
25. S. Zhang, B. Pavlovitz, J. Tull, Y. Wang, F.M. Deng, and C. Fuller Detection of TMPRSS2 gene deletions and translocations in carcinoma, intraepithelial neoplasia, and normal epithelium of the prostate by direct fluorescence in situ hybridization Diagn Mol Pathol 19 2010 151 156
26. C. Ruiz, E. Lenkiewicz, and L. Evers Advancing a clinically relevant perspective of the clonal nature of cancer Proc Natl Acad Sci USA 108 2011 12054 12059
27. B. Furusato, S.H. Tan, and D. Young ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification Prostate Cancer Prostatic Dis 13 2010 228 237
28. H. He, A.O. Osunkoya, and P. Carver Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): lack of utility to stratify cancer risks associated with HGPIN BJU Int 110 2012 E751 E755
29. J.M. Mosquera, S. Perner, and F. Demichelis Morphological features of TMPRSS2-ERG gene fusion prostate cancer J Pathol 212 2007 91 101